![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Rodríguez-Mañas Leocadio
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.30, Iss.5, 2010-05, pp. : 337-345
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Reviparin sodium – a new low molecular weight heparin
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Low-Molecular-Weight Heparin in Acute Coronary Syndromes
Heart Drug, Vol. 4, Iss. 3, 2004-08 ,pp. :